| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5560903 | GE HEALTHCARE | Method of enhancing paramagnetism in chelates for MRI |
Oct, 2013
(10 years ago) | |
Omniscan is owned by Ge Healthcare.
Omniscan contains Gadodiamide.
Omniscan has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Omniscan are:
- US5560903
Omniscan was authorised for market use on 08 January, 1993.
Omniscan is available in injectable;injection dosage forms.
The generics of Omniscan are possible to be released after 01 October, 2013.
Drugs and Companies using GADODIAMIDE ingredient
Market Authorisation Date: 08 January, 1993
Treatment: NA
Dosage: INJECTABLE;INJECTION
More Information on Dosage
OMNISCAN family patents
